Lilly earnings increase as Mounjaro, Zepbound sales continue rise
The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.
Daniel Bradley
Articles
Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine
The Indianapolis-based drugmaker will partner with Profluent to develop and commercialize treatments for diseases with severe unmet needs.
Lilly acquiring cancer-drug firm Ajax Therapeutics in deal worth up to $2.3B
The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.
Complex process leads to a new drug’s identity
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.
Central Indiana excelling in life sciences, but it needs a brand, speakers say
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.
Q&A: Cardiologist has spent career working on treatment for rare condition
Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley Children’s Health, has been working on a treatment for a neurodegenerative condition called Friedreich’s ataxia for decades.
IU, Zimmer Biomet forge 3-year partnership to advance orthopedic sector
The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.
Community Health Network Foundation names new CEO
Derek B. Groves will join Community Health Network Foundation in May as part of a planned leadership transition. He will succeed longtime CEO Joyce Irwin.
Ossium Health aims to revolutionize role of bone marrow banks
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
Greene County hospital serves Anthem with breach notice over underpayments
Hospital CEO Brenda Reetz the insurance underpayment situation impacts patient bills, hospital stability and access to care. Indianapolis-based Anthem said it is working with the hospital to resolve the problem.
Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies
Through the collaboration, Telix and Regeneron expect to develop and commercialize next-generation radiopharmaceutical therapies targeting cancer.
Corteva names CEO for ‘New Corteva’ crop protection spinoff
Luke Kissam will lead New Corteva after Corteva officially separates its pesticide and seed businesses into two independent, publicly traded companies.
Q&A: CEO Kristin Nunery says an insurance battle after a house fire led to her company
Nunery explains how she led her company — Illumend powered by myCOI — from an RV while traveling the country during the pandemic.
Former IU researcher pleads guilty to smuggling E. coli DNA from China to U.S.
Youhuang Xiang, 32, will receive prison time and be deported as part of his sentence.
Eli Lilly weight-loss pill Foundayo now available in United States
The Indianapolis-based drugmaker has started shipping the new pill to retail pharmacies.
Nearly $2B in funding for new Indianapolis VA hospital included in federal budget proposal
The budget proposal calls for a new 840,000-square-foot tower that would replace the aging Richard L. Roudebush Veterans Administration Medical Center.
IU researchers play role in development of new bladder cancer treatment
The treatment uses a combination of two drugs to battle the cancer in addition to surgery to remove tumors.
Boone County’s Witham Health Services plans to join Parkview Health
Witham’s announcement comes amid a series of recent moves by Parkview Health involving expansion into areas of the state away from its headquarters in Fort Wayne.
BSA LifeStructures grows by keeping focus on strengths
CEO Tim Spence says the design firm does not stray from its core industries of health care, higher education and scientific research. In BSA lingo, that’s healing, learning and discovery.
IU names board of nonprofit for real estate, research and life sciences work
Pamela Whitten, president of Indiana University, will serve as chair of the IU Inc. board of directors.